Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma

BACKGROUND: Growing evidence has indicated that tumor biomarkers, including cytokeratin 19 fragment antigen 21–1 (Cyfra21–1), carbohydrate antigen 19–9 (CA19–9), carbohydrate antigen 72–4 (CA72–4), carcinoembryonic antigen (CEA) and squamous cell carcinoma antigen (SCC-Ag) were reported to be common...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMC Cancer
Autores principales: Yang, Yuchong, Huang, Xuanzhang, Zhou, Likun, Deng, Ting, Ning, Tao, Liu, Rui, Zhang, Le, Bai, Ming, Zhang, Haiyang, Li, Hongli, Ba, Yi
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6544972/
https://ncbi.nlm.nih.gov/pubmed/31151431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5755-5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares